Association between CT-Based Preoperative Sarcopenia and Outcomes in Patients That Underwent Liver Resections.
Association between CT-Based Preoperative Sarcopenia and Outcomes in Patients That Underwent Liver Resections.
复制标题
DOI:
10.3390/cancers14010261
复制
发表时间:
2022-01-05
期刊:
影响因子:
5.2
通讯作者:
Uldry E
中科院分区:
文献类型:
--
作者:
Martin D;Maeder Y;Kobayashi K;Schneider M;Koerfer J;Melloul E;Halkic N;Hübner M;Demartines N;Becce F;Uldry E
Cancer cachexia often includes sarcopenia, which is characterized by a progressive, generalized loss of skeletal muscle mass and strength, combined with fatty infiltration into the muscle. Sarcopenia has been considered a patient-specific imaging biomarker for predicting outcomes after cancer surgery. The present study aimed to evaluate whether preoperative sarcopenia was associated with postoperative outcomes and survival in patients that underwent liver resections. Sarcopenia, assessed by preoperative CT imaging, was present in two-thirds of patients. Independent risk factors for sarcopenia were age, male sex, ASA score ≥ 3, and malignancies. Based on CT assessment alone, sarcopenia had no impact on clinical outcomes or overall survival after hepatectomy. This retrospective observational study aimed to evaluate whether preoperative sarcopenia, assessed by CT imaging, was associated with postoperative clinical outcomes and overall survival in patients that underwent liver resections. Patients operated on between January 2014 and February 2020 were included. The skeletal muscle index (SMI) was measured at the level of the third lumbar vertebra on preoperative CT scans. Preoperative sarcopenia was defined based on pre-established SMI cut-off values. The outcomes were postoperative morbidity, length of hospital stay (LOS), and overall survival. Among 355 patients, 212 (59.7%) had preoperative sarcopenia. Patients with sarcopenia were significantly older (63.5 years) and had significantly lower BMIs (23.9 kg/m2) than patients without sarcopenia (59.3 years, p < 0.01, and 27.7 kg/m2, p < 0.01, respectively). There was no difference in LOS (8 vs. 8 days, p = 0.75), and the major complication rates were comparable between the two groups (11.2% vs. 11.3%, p = 1.00). The median overall survival times were comparable between patients with sarcopenia and those without sarcopenia (15 vs. 16 months, p = 0.87). Based on CT assessment alone, preoperative sarcopenia appeared to have no impact on postoperative clinical outcomes or overall survival in patients that underwent liver resections. Future efforts should also consider muscle strength and physical performance, in addition to imaging, for preoperative risk stratification.
登录
查看更多内容
DOI:
10.1016/j.jamcollsurg.2010.03.039
发表时间:
2010-08
影响因子:
5.2
作者:
Englesbe, Michael J.;Patel, Shaun P.;He, Kevin;Lynch, Raymond J.;Schaubel, Douglas E.;Harbaugh, Calista;Holcombe, Sven A.;Wang, Stewart C.;Segev, Dorry L.;Sonnenday, Christopher J.
通讯作者:
Sonnenday, Christopher J.
DOI:
10.1111/apha.12224
发表时间:
2014-03
期刊:
Acta physiologica (Oxford, England)
影响因子:
--
作者:
Aubrey J;Esfandiari N;Baracos VE;Buteau FA;Frenette J;Putman CT;Mazurak VC
通讯作者:
Mazurak VC
影响因子:
--
作者:
Carli, Francesco;Scheede-Bergdahl, Celena
通讯作者:
Scheede-Bergdahl, Celena
影响因子:
3.8
作者:
Franken, Lotte C.;Schreuder, Anne Marthe;van Gulik, Thomas M.
通讯作者:
van Gulik, Thomas M.
影响因子:
2.6
作者:
Graffy, Peter M.;Liu, Jiamin;Summers, Ronald M.
通讯作者:
Summers, Ronald M.